Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Updated by StockNews.com to “Strong-Buy”

0

Fresenius Medical Care AG & Co. KGaA (NYSE: FMS – Get a rating) has been updated by equity research analysts from StockNews.com from a “buy” rating to a “strong buy” rating in a research note released on Friday.

FMS has been the subject of several other reports. Truist Financial lowered its price target on shares of Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a “holding” rating for the company in a Wednesday 22 research report. June. Jefferies Financial Group downgraded shares of Fresenius Medical Care AG & Co. KGaA from an “underperforming” rating to a “buy” rating and raised its price target for the company from $30.30 to 33, $70 in a research report released Monday. Berenberg Bank lowered its price target on shares of Fresenius Medical Care AG & Co. KGaA from €84.90 ($90.32) to €83.40 ($88.72) in a Thursday research report March 17. Finally, JPMorgan Chase & Co. raised its price target on shares of Fresenius Medical Care AG & Co. KGaA from €48.70 ($51.81) to €51.00 ($54.26) and assigned the company an “underweight” rating in a research report on Thursday, May 5. One financial analyst gave the stock a sell rating, six gave the stock a hold rating, four gave the stock a buy rating and one gave the stock a strong buy rating. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $52.51.

(A d)

The video reveals the most powerful trade you’ve EVER heard of. Released every Tuesday, it could DOUBLE your money by Friday.

Over the past 3 years, he has won 321 of those 324 trades, with the majority making 100%+ every 3-10 days.

Find out how a simple 10 minute trade on Tuesday could double your money by Friday.

Watch the video now for more details.

Shares of Fresenius Medical Care AG & Co. KGaA opened at $24.94 on Friday. The company has a debt ratio of 0.51, a current ratio of 1.26 and a quick ratio of 0.93. Fresenius Medical Care AG & Co. KGaA has a 1-year minimum of $23.29 and a 1-year maximum of $42.13. The company’s 50-day moving average is $28.74 and its two-hundred-day moving average is $31.41. The stock has a market capitalization of $14.62 billion, a price/earnings ratio of 14.25, a PEG ratio of 1.03 and a beta of 1.17.

Fresenius Medical Care AG & Co. KGaA (NYSE: FMS – Get a rating) last reported results on Wednesday, May 4. The company reported earnings per share (EPS) of $0.38 for the quarter, beating the consensus estimate of $0.30 by $0.08. The company posted revenue of $5.10 billion for the quarter, versus $4.97 billion expected by analysts. Fresenius Medical Care AG & Co. KGaA achieved a net margin of 4.91% and a return on equity of 6.99%. On average, stock analysts expect Fresenius Medical Care AG & Co. KGaA to post earnings per share of 1.93 for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the company. Ellevest Inc. increased its position in Fresenius Medical Care AG & Co. KGaA by 96.6% during the 4th quarter. Ellevest Inc. now owns 1,148 shares of the company worth $37,000 after purchasing an additional 564 shares in the last quarter. First PREMIER Bank increased its position in Fresenius Medical Care AG & Co. KGaA by 118.6% during the 4th quarter. First PREMIER Bank now owns 1,290 shares of the company worth $42,000 after purchasing an additional 700 shares in the last quarter. Tcwp LLC purchased a new position in Fresenius Medical Care AG & Co. KGaA during Q1 for a value of approximately $44,000. SRS Capital Advisors Inc. increased its position in Fresenius Medical Care AG & Co. KGaA by 36.0% during the 1st quarter. SRS Capital Advisors Inc. now owns 1,545 shares of the company worth $52,000 after buying 409 additional shares in the last quarter. Finally, Creative Financial Designs Inc. ADV acquired a new equity stake in Fresenius Medical Care AG & Co. KGaA during Q1 for a value of approximately $67,000. 4.73% of the shares are held by institutional investors.

About Fresenius Medical Care AG & Co. KGaA (Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Further reading

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Fresenius Medical Care AG & Co. KGaA right now?

Before you consider Fresenius Medical Care AG & Co. KGaA, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes a turn… and Fresenius Medical Care AG & Co. KGaA was not on the list.

While Fresenius Medical Care AG & Co. KGaA currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Share.

Comments are closed.